Unlike XRCC6 expression, which was not associated with survival in the Total Therapy 2 (TT2) myeloma dataset used here (n = 351), the message levels of FANCD2 were significantly correlated with event-free and overall survival of patients with myeloma. Here, XRCC6 is linked to plasma cell myeloma.